1.
Br J Dermatol
; 181(3): 609-611, 2019 09.
Article
in English
| MEDLINE
| ID: mdl-30801662
Subject(s)
Antibodies, Monoclonal, Humanized/administration & dosage , Hidradenitis Suppurativa/drug therapy , Interleukin-17/antagonists & inhibitors , Quality of Life , Adult , Antibodies, Monoclonal, Humanized/adverse effects , Female , Hidradenitis Suppurativa/complications , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/immunology , Humans , Injections, Subcutaneous , Interleukin-17/immunology , Male , Middle Aged , Pilot Projects , Severity of Illness Index , Treatment Outcome
2.
Br J Anaesth
; 116(4): 564-6, 2016 Apr.
Article
in English
| MEDLINE
| ID: mdl-26994241